Salmonella susceptibility

Science

Volumn 328, Issue 5977, 2010, Pages 439-440

  Moir, Susan ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CD4 ANTIGEN; LIPOPOLYSACCHARIDE; OUTER MEMBRANE PROTEIN; BLOCKING ANTIBODY;

ANTIBODY; ANTIMICROBIAL ACTIVITY; BACTERIUM; HEALTH SERVICES; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNITY; MORBIDITY; MORTALITY;

BACTEREMIA; CD4+ T LYMPHOCYTE; GASTROENTERITIS; GASTROINTESTINAL MUCOSA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; LYMPHOCYTE DEPLETION; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; SHORT SURVEY; AIDS RELATED COMPLEX; ANIMAL; BLOOD; DISEASE PREDISPOSITION; IMMUNOLOGY; MOUSE; NOTE; SALMONELLOSIS;

SALMONELLA;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, BLOCKING; BACTEREMIA; BACTERIAL OUTER MEMBRANE PROTEINS; DISEASE SUSCEPTIBILITY; HIV INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MICE; SALMONELLA; SALMONELLA INFECTIONS;

EID: 77951597509     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1189088     Document Type: Short Survey

References (9)

1. Centers for Disease Control and Prevention, MMWR Recomm. Rep. 41,1 (1993).
2. Y. Chimalizeni, K. Kawaza, E. Molyneux, Adv. Exp. Med. Biol. 659, 33 (2010).
3. C. A. MacLennan et. al., Science 328, 508 (2010).
4. R. L. Santos et. al., Trends Microbiol. 17, 498 (2009).
5. C. A. MacLennan et al., J. Clin. Invest. 118, 1553 (2008).
6. H. C. Lane et al., N. Engl. J. Med. 309, 453 (1983).
7. S. Moir, A. S. Fauci, Nat. Rev. Immunol. 9, 235 (2009).
8. J. M. Brenchley et al., Nat. Med. 12,1365 (2006).
9. M. Raffatellu et al., Nat. Med. 14, 421 (2008).